RepertoireID™ An analytical module of the ImmunoID NeXT PlatformTM Comprehensive Profiling of the TCR Repertoire RepertoireID, an analytics module of the ImmunoID NeXT Platform, enables the detection and analysis of the top TCRβ clones in the TCR repertoire found in the tumor microenvironment (TME) of patients’ tumors. The RNA [...]
NeoantigenID™ An analytical module of the ImmunoID NeXT PlatformTM Comprehensive Identification of Putative Neoantigens Neoantigens are mutated peptides that are expressed by tumor cells, but not by normal tissue. As a result, they can be recognized as foreign antigens by cells of the immune system — making them promising [...]
ImmunogenomicsID An analytical module of the ImmunoID NeXT PlatformTM Comprehensive Immunogenomic Characterization ImmunogenomicsID, an analytical module of the ImmunoID NeXT Platform, characterizes critical areas of tumor biology such as the antigen processing machinery (APM), human leukocyte antigens (HLA), checkpoint modulation, and tumor escape, while also providing a readout on [...]
NeoantigenID™ Comprehensive identification of putative neoantigens Neoantigens are mutated peptides that are expressed by tumor cells, but not by normal tissue. As a result, they can be recognized as foreign antigens by cells of the immune system — making them promising targets for personalized cancer immunotherapies such as vaccines [...]
ImmunogenomicsID™ Comprehensive immunogenomic characterization ImmunogenomicsID™, the latest analytics component of the ACE ImmunoID platform, summarizes critical areas of tumor biology such as the antigen processing machinery (APM), human leukocyte antigens (HLA), checkpoint modulation, and tumor escape. ImmunogenomicsID combines exome and transcriptome sequencing data from a paired tumor and normal [...]
Increasingly, oncologists and pathologists are utilizing information on genomic alterations in solid tumors, such as lung, colon, breast, skin, and prostate cancers, to help guide and optimize therapeutic options for patients.
Clinical Reports for Today, Data for the Future Personalis ACE CancerPlus Test is a comprehensive genomic testing solution that provides physicians a clinical report on the genetic alterations found in cancer genes of medical importance.
